Bayer has received MHRA approval for Kerendia (finerenone) for adults in the UK with symptomatic chronic heart failure and a left ventricular ejection fraction of 40% or above. Th ...

Transgene has completed patient randomisation in the phase 2 part of its phase 1/2 clinical trial evaluating TG4050, an individualised neoantigen therapeutic vaccine being developed for the adjuvant ...

A British inquiry into the use of chemotherapy to treat seriously ill cancer patients has found the treatment caused or hastened death in 27% of cases. A British inquiry into the use of chemotherapy ...

Gedeon Richter UK has assumed full marketing and distribution responsibilities for the neuropsychiatry medicine cariprazine following the transfer of rights from Recordati Pharmaceuticals. The move ...

Partnership to develop next‑generation T‑cell engagers for solid tumours Oxford BioTherapeutics has entered a multi‑year collaboration with Bristol Myers Squibb to discover and develop novel T‑cell ...

New MHRA–FDA collaboration aims to boost patient access and AI safety Patients in the UK are set to benefit from a strengthened partnership between the Medicines and Healthcare products Regulatory ...

Novo Nordisk has announced its plans to open a new, artificial intelligence (AI)-based research facility to advance drug discovery operations in London. The new hub will be located in King’s Cross’s ...

Brekiya is now the first DHE auto-injector to be approved by the regulator The US Food and Drug Administration (FDA) has approved Amneal Pharmaceuticals’ Brekiya (dihydroergotamine mesylate) injection ...

New funding will support the phase 2 expansion trial of THEO-260 The Oxford-based biotechnology company Theolytics has been awarded €8 million in non-dilutive grant funding from Horizon Europe 2025.

Six new Grand Challenges aim to tackle drug resistance and accelerate antibiotic discovery GSK and the Fleming Initiative have announced six new research programmes to combat antimicrobial resistance ...

A widely recognised impact of the pandemic on the clinical trials landscape has been the increasing use of JIT methods for clinical trial supply and distribution, with many organizations compelled to ...

Funding to accelerate development of AI-driven tumour profiling tool OneMap One Biosciences has secured €15 million in Series A financing to expand its AI-powered single-cell transcriptomic platform, ...